Carmel Jo Pezaro, MB, ChB, on Prostate Cancer and PARP Inhibitors

Posted: Thursday, July 5, 2018

Carmel Jo Pezaro, MB, ChB, of Monash University, discusses the optimal integration of PARP inhibitors for prostate cancer: which test, patient, and therapy.